within the context of the regulatory hazard assessment show much higher heterogeneity with regard to test species, test protocols, and measured toxic effects.
The current situation regarding test development, validation status, and regulatory acceptance is described for each of the major toxicity endpoints required for regulatory hazard assessment.
As a consequence, a virtually unlimited number of different nanomaterials can be identified, which may result in a burdensome request for a large amount of toxicological data for regulatory hazard assessment.
Based on the literature review, it can be concluded that the advantage of considering alternative endpoints as additional input for a regulatory hazard assessment specific for ENMs is limited so far.
The availability of this wealth of new toxicological data, together with the promotion of REACH of in silico methods, appoints medicinal chemists to a leading role in the regulatory hazard assessment process.
By drawing upon the strengths of academic and regulatory expertise and research approaches, CLARITY-BPA represents a potential new model for filling knowledge gaps, enhancing quality control, informing chemical risk assessment, and identifying new methods or endpoints for regulatory hazard assessments.
It represents a new model for filling knowledge gaps and enhancing the value of investments in research, developing and promoting best methods and practices, informing chemical risk assessment, and identifying new methods or end points with the potential to improve regulatory hazard assessments and enhance protection of humans.
But, he said, Ms. Martin told him that under the new regulatory system, such hazards were not a high priority unless they threatened to directly contaminate meat.
Despite challenges in the integration of omics into risk assessment, some omics methods have already been used by regulatory agencies for hazard identification.
